Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
techniques are essential, as is a demonstrable expertise in advanced microscopy and cytogenetics. This is a full-time position available fixed-term for 12 months from October 2024, funded by Cancer Research UK
-
holidays. Local and national discounts at a range of major retailers. Why choose Cancer Research UK Manchester Institute? The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute
-
In 2013, Europe's top cancer charity, Cancer Research UK, combined with the University of Cambridge to fund the world class Cancer Research UK Cambridge Institute, situated on the Addenbrooke's
-
The Wellcome Trust/Cancer Research UK Gurdon Institute is seeking a part time (0.5 FTE) Research Grants Administrator to compliment the Finance team. In this role you will provide the Institute with
-
Research UK Manchester Institute (www.cruk.manchester.ac.uk ), an Institute of The University of Manchester (www.manchester.ac.uk ), The Biomarker Centre and Manchester Institute are core funded by Cancer
-
organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed
-
: Monday 10 June 2024 Interview Date: To be confirmed Reference: 2719324CM Exploiting the innate and adaptive immune interface for effective cancer therapy (Cancer Research UK) We are seeking to recruit a
-
2024 Reference: 2719324CM Exploiting the innate and adaptive immune interface for effective cancer therapy (Cancer Research UK) We are seeking to recruit a highly motivated and capable postdoctoral
-
; Max Planck Institute for Human Cognitive and Brain Sciences | London, England | United Kingdom | about 6 hours ago
Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central
-
. This post funded by a Cancer Research UK (CRUK) Programme Foundation Award is available from April 2024. Dr Munoz-Espin's research programme aims to understand the mechanisms and processes